BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 31213793)

  • 1. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions.
    Hanania NA; O'Donnell DE
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1127-1138. PubMed ID: 31213793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyspnea in COPD: New Mechanistic Insights and Management Implications.
    O'Donnell DE; Milne KM; James MD; de Torres JP; Neder JA
    Adv Ther; 2020 Jan; 37(1):41-60. PubMed ID: 31673990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for cognitive-behavioral strategies improving dyspnea and related distress in COPD.
    Norweg A; Collins EG
    Int J Chron Obstruct Pulmon Dis; 2013; 8():439-51. PubMed ID: 24106423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of dyspnea in COPD.
    Anzueto A; Miravitlles M
    Postgrad Med; 2017 Apr; 129(3):366-374. PubMed ID: 28277858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New physiological insights into dyspnea and exercise intolerance in chronic obstructive pulmonary disease patients.
    Laveneziana P; Guenette JA; Webb KA; O'Donnell DE
    Expert Rev Respir Med; 2012 Dec; 6(6):651-62. PubMed ID: 23234451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable.
    O'Donnell DE; Banzett RB; Carrieri-Kohlman V; Casaburi R; Davenport PW; Gandevia SC; Gelb AF; Mahler DA; Webb KA
    Proc Am Thorac Soc; 2007 May; 4(2):145-68. PubMed ID: 17494725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD patients' experiences, self-reported needs, and needs-driven strategies to cope with self-management.
    Sigurgeirsdottir J; Halldorsdottir S; Arnardottir RH; Gudmundsson G; Bjornsson EH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1033-1043. PubMed ID: 31190788
    [No Abstract]   [Full Text] [Related]  

  • 8. Development of a Standard Set of Outcome Domains and Proposed Measures for Chronic Obstructive Pulmonary Disease in Primary Care Physical Therapy Practice in the Netherlands: a Modified RAND/UCLA Appropriateness Method.
    Verburg AC; van Dulmen SA; Kiers H; Ypinga JH; Nijhuis-van der Sanden MW; van der Wees PJ
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2649-2661. PubMed ID: 31819398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPD: the patient perspective.
    Jones PW; Watz H; Wouters EF; Cazzola M
    Int J Chron Obstruct Pulmon Dis; 2016; 11 Spec Iss(Spec Iss):13-20. PubMed ID: 26937186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pathophysiology of Dyspnea and Exercise Intolerance in Chronic Obstructive Pulmonary Disease.
    O'Donnell DE; James MD; Milne KM; Neder JA
    Clin Chest Med; 2019 Jun; 40(2):343-366. PubMed ID: 31078214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological mechanisms of exertional breathlessness in chronic obstructive pulmonary disease and interstitial lung disease.
    Jensen D; Schaeffer MR; Guenette JA
    Curr Opin Support Palliat Care; 2018 Sep; 12(3):237-245. PubMed ID: 30074922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cross-sectional assessment of the burden of COPD symptoms in the US and Europe using the National Health and Wellness Survey.
    Ding B; DiBonaventura M; Karlsson N; Bergström G; Holmgren U
    Int J Chron Obstruct Pulmon Dis; 2017; 12():529-539. PubMed ID: 28223793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study.
    Kulich K; Keininger DL; Tiplady B; Banerji D
    Int J Chron Obstruct Pulmon Dis; 2015; 10():79-94. PubMed ID: 25609942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ventilatory constraints and dyspnea during exercise in chronic obstructive pulmonary disease.
    Laveneziana P; Parker CM; O'Donnell DE
    Appl Physiol Nutr Metab; 2007 Dec; 32(6):1225-38. PubMed ID: 18059601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.
    O'Donnell DE
    Proc Am Thorac Soc; 2006 Apr; 3(2):180-4. PubMed ID: 16565429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Dyspnea and Anxiety in Chronic Obstructive Pulmonary Disease: A Critical Review.
    Yohannes AM; Junkes-Cunha M; Smith J; Vestbo J
    J Am Med Dir Assoc; 2017 Dec; 18(12):1096.e1-1096.e17. PubMed ID: 29108885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment.
    Langer D; Ciavaglia CE; Neder JA; Webb KA; O'Donnell DE
    Expert Rev Respir Med; 2014 Dec; 8(6):731-49. PubMed ID: 25159007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological management of breathlessness in COPD: recent advances and hopes for the future.
    O'Donnell DE; Webb KA; Harle I; Neder JA
    Expert Rev Respir Med; 2016 Jul; 10(7):823-34. PubMed ID: 27115291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between exercise capacity and different functional markers in pulmonary rehabilitation for COPD.
    Kerti M; Balogh Z; Kelemen K; Varga JT
    Int J Chron Obstruct Pulmon Dis; 2018; 13():717-724. PubMed ID: 29535512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new functional status outcome measure of dyspnea and anxiety for adults with lung disease: the dyspnea management questionnaire.
    Migliore Norweg A; Whiteson J; Demetis S; Rey M
    J Cardiopulm Rehabil; 2006; 26(6):395-404. PubMed ID: 17135861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.